JP2022549362A5 - - Google Patents
Info
- Publication number
- JP2022549362A5 JP2022549362A5 JP2022519481A JP2022519481A JP2022549362A5 JP 2022549362 A5 JP2022549362 A5 JP 2022549362A5 JP 2022519481 A JP2022519481 A JP 2022519481A JP 2022519481 A JP2022519481 A JP 2022519481A JP 2022549362 A5 JP2022549362 A5 JP 2022549362A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- nos
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962907275P | 2019-09-27 | 2019-09-27 | |
| US62/907,275 | 2019-09-27 | ||
| US202062989327P | 2020-03-13 | 2020-03-13 | |
| US62/989,327 | 2020-03-13 | ||
| PCT/US2020/053064 WO2021062361A2 (en) | 2019-09-27 | 2020-09-28 | Monospecific and multi-specific antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022549362A JP2022549362A (ja) | 2022-11-24 |
| JP2022549362A5 true JP2022549362A5 (https=) | 2023-10-11 |
Family
ID=75166476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519481A Pending JP2022549362A (ja) | 2019-09-27 | 2020-09-28 | 一重特異性および多重特異性抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230340157A1 (https=) |
| EP (1) | EP4034549A4 (https=) |
| JP (1) | JP2022549362A (https=) |
| KR (1) | KR20220070249A (https=) |
| CN (1) | CN115052884B (https=) |
| AU (1) | AU2020353182A1 (https=) |
| CA (1) | CA3156160A1 (https=) |
| WO (1) | WO2021062361A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| WO2022109987A1 (en) * | 2020-11-27 | 2022-06-02 | Shanghai Benemae Pharmaceutical Corporation | Novel anti-lag3 antibodies and methods of making and using the same |
| WO2023274183A1 (zh) * | 2021-06-29 | 2023-01-05 | 江苏先声药业有限公司 | Cd16抗体及其应用 |
| US20250388669A1 (en) * | 2022-01-21 | 2025-12-25 | Jieyi Wang | Multi-specific antibodies in uses thereof in avidity receptor crosslinking and immune modulation |
| WO2023224412A1 (ko) * | 2022-05-19 | 2023-11-23 | (주)샤페론 | Pd-l1 및 cd47에 대한 이중특이적 인간화 단일 도메인 항체 및 이의 용도 |
| CN119768433A (zh) * | 2022-06-28 | 2025-04-04 | 珠海烁星生物医药科技有限公司 | 单特异性和多特异性抗体 |
| CN118255894A (zh) * | 2022-12-27 | 2024-06-28 | 广东菲鹏制药股份有限公司 | 一种双特异性结合分子及其应用 |
| WO2025101526A1 (en) * | 2023-11-06 | 2025-05-15 | Beijing Starmab Biomed Technology Ltd | Multi-specific cancer-targeting antibodies |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006517789A (ja) * | 2003-01-10 | 2006-08-03 | アブリンクス エン．ヴェー． | 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用 |
| EP2658869B1 (en) * | 2010-12-30 | 2019-06-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antigen binding formats for use in therapeutic treatments or diagnostic assays |
| KR102100388B1 (ko) * | 2012-02-06 | 2020-04-13 | 인히브릭스, 인크. | Cd47 항체 및 그 사용 방법 |
| WO2014198748A1 (en) * | 2013-06-11 | 2014-12-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anti-her2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer |
| WO2015095412A1 (en) * | 2013-12-19 | 2015-06-25 | Zhong Wang | Bispecific antibody with two single-domain antigen-binding fragments |
| PL3560954T3 (pl) * | 2014-04-03 | 2021-12-13 | Igm Biosciences, Inc. | Zmodyfikowany łańcuch J |
| CN104804093A (zh) * | 2015-05-27 | 2015-07-29 | 江苏春申堂药业有限公司 | 一种针对cd47的单域抗体 |
| CN106432502B (zh) * | 2015-08-10 | 2020-10-27 | 中山大学 | 用于治疗cea阳性表达肿瘤的双特异纳米抗体 |
| EP3502142B1 (en) * | 2016-06-22 | 2021-10-27 | Benhealth Biopharmaceutic (Shenzhen) Co., Ltd. | Bispecific antibody and antibody conjugate for tumour therapy and use thereof |
| CN109096395B (zh) * | 2017-06-20 | 2022-06-24 | 华兰生物工程股份有限公司 | 阻断型cd47纳米抗体及其用途 |
| EA039662B1 (ru) * | 2017-10-03 | 2022-02-24 | Закрытое Акционерное Общество "Биокад" | Антитела, специфичные к cd47 и pd-l1 |
| EP3724338A4 (en) * | 2017-12-14 | 2021-09-29 | Salk Institute for Biological Studies | GENETICALLY CODED FLUORESCENT IRON FERRITIN NANOPARTICLE PROBES FOR INTRACELLULAR TARGET DETECTION BY FLUORESCENT AND ELECTRONIC MICROSCOPY |
| CN110144009B (zh) * | 2018-02-14 | 2020-01-21 | 上海洛启生物医药技术有限公司 | Cd47单域抗体及其用途 |
| CN110003335B (zh) * | 2019-04-12 | 2023-07-04 | 深圳普瑞金生物药业股份有限公司 | Cd47单域抗体、核酸及试剂盒 |
| US20210324477A1 (en) * | 2020-04-21 | 2021-10-21 | Grail, Inc. | Generating cancer detection panels according to a performance metric |
| US11791597B2 (en) * | 2021-02-05 | 2023-10-17 | Aptiv Technologies (2) S.À R.L. | Flexible electrical bus bar and method of manufacturing the same |
| CN119768433A (zh) * | 2022-06-28 | 2025-04-04 | 珠海烁星生物医药科技有限公司 | 单特异性和多特异性抗体 |
-
2020
- 2020-09-28 US US17/763,582 patent/US20230340157A1/en active Pending
- 2020-09-28 WO PCT/US2020/053064 patent/WO2021062361A2/en not_active Ceased
- 2020-09-28 CN CN202080082179.3A patent/CN115052884B/zh active Active
- 2020-09-28 AU AU2020353182A patent/AU2020353182A1/en not_active Abandoned
- 2020-09-28 EP EP20868232.8A patent/EP4034549A4/en active Pending
- 2020-09-28 KR KR1020227013335A patent/KR20220070249A/ko active Pending
- 2020-09-28 CA CA3156160A patent/CA3156160A1/en active Pending
- 2020-09-28 JP JP2022519481A patent/JP2022549362A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022549362A5 (https=) | ||
| JP2020023523A5 (https=) | ||
| JP2023113950A5 (https=) | ||
| JP2023540732A5 (https=) | ||
| JP2019536430A5 (https=) | ||
| JP2024167313A5 (https=) | ||
| JP2022523507A5 (https=) | ||
| PE20231851A1 (es) | Proteinas que se unen a nkg2d, cd16 y clec12a | |
| JP2024522357A5 (https=) | ||
| JP2022512653A5 (https=) | ||
| JP2022553324A5 (https=) | ||
| JP2018502050A5 (https=) | ||
| JP2019515646A5 (https=) | ||
| JP6608698B2 (ja) | Ｐ２ｘ７受容体アンタゴニスト及びアゴニスト | |
| IL271817B1 (en) | Bispecific anti PD-1/PD-L1 antibodies and uses thereof | |
| JP2010539921A5 (https=) | ||
| JP2018505674A5 (https=) | ||
| JP2017511130A5 (https=) | ||
| CN103687879A (zh) | 多价抗原结合fv分子 | |
| JP2014533239A5 (https=) | ||
| MD3191511T2 (ro) | Lianți TNF îmbunătățiți | |
| JP2020529410A5 (https=) | ||
| JP2022524337A5 (https=) | ||
| JP2014158485A5 (https=) | ||
| JP2020500510A5 (https=) |